Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Our innovative affective AI platform, DeepAffex, identifies, quantifies, and interprets human emotions manifested through both physiological and psychological states. This cloud-based solution employs sophisticated machine learning models to analyze these human affects, ensuring that all computational tasks are handled seamlessly in the cloud environment. Developers have the opportunity to create their own applications or software solutions utilizing our SDK/API, enabling them to retrieve measurement results from the DeepAffex cloud service across a variety of devices, including smartphones, tablets, desktops, kiosks, and web browsers. Additionally, accessing updates from our cloud service is straightforward, allowing users to enhance their capabilities with new measurement features effortlessly. The DeepAffex dashboard serves as a web-based management interface, designed specifically for developers and system administrators, providing a secure way for authorized personnel to oversee their organization’s private accounts on the DeepAffex cloud. With its user-friendly design, DeepAffex aims to streamline the integration of affective analysis into various applications, fostering enhanced emotional intelligence in technology.

Description

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

NuraLogix

Country

Canada

Website

nuralogix.ai/deep-affex/

Vendor Details

Company Name

Valar Labs

Founded

2021

Country

United States

Website

www.valarlabs.com

Product Features

Product Features

Alternatives

Alternatives

Oncora Reviews

Oncora

Oncora Medical
Affect-Tag RX Reviews

Affect-Tag RX

Neotrope
iKnowMed Reviews

iKnowMed

McKesson
LARVOL CLIN Reviews

LARVOL CLIN

LARVOL
Altai Oncology Suite Reviews

Altai Oncology Suite

Altai Oncology